Italia markets close in 4 hours 38 minutes

Inari Medical, Inc. (NARI)

NasdaqGS - NasdaqGS Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
47,40+1,29 (+2,80%)
Alla chiusura: 04:00PM EDT
46,50 -0,90 (-1,90%)
Dopo ore: 05:28PM EDT
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente46,11
Aperto46,56
Denaro47,30 x 400
Lettera47,56 x 200
Min-Max giorno45,55 - 48,34
Intervallo di 52 settimane39,90 - 71,85
Volume2.151.062
Media Volume1.003.919
Capitalizzazione2,747B
Beta (5 anni mensile)0,84
Rapporto PE (ttm)N/D
EPS (ttm)-0,03
Prossima data utili01 mag 2024 - 06 mag 2024
Rendimento e dividendo (futuro)N/D (N/D)
Data ex dividendoN/D
Stima target 1A74,27
  • GlobeNewswire

    Inari Medical to Announce Third Quarter 2023 Financial Results

    IRVINE, Calif., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced today that it will release its third quarter 2023 financial results on Wednesday, November 1, 2023. In conjunction with the release, Inari will host a conference call and webcast at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and

  • GlobeNewswire

    Inari Medical to Present at Upcoming Investor Conferences

    IRVINE, Calif., Aug. 24, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced today that its management team will present at the following investor conferences: 2023 Wells Fargo Healthcare ConferencePresenting on Friday, September 8, 2023 at 8:45 a.m. Eastern Time in Boston, MA at the Encore Boston Harbor 21st Annual Morgan Stanley Global Heal

  • GlobeNewswire

    Inari Medical Reports Second Quarter 2023 Financial Results

    IRVINE, Calif., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today reported financial results for its second quarter ended June 30, 2023. Second Quarter Financial and Recent Business Highlights Generated revenue of $119.0 million in Q2 of 2023, up 28.3% over the same quarter last year.Delivered net income of $2.1 million in Q2 of 2023,